Effect of Intrathecal Morphine on Quality of Recovery After Laparoscopic Colorectal Cancer Surgery
1 other identifier
interventional
252
1 country
1
Brief Summary
Colorectal cancer is the second most common tumor in women and the third most common tumor in men, accounting for approximately 10% of tumors diagnosed and tumor-related deaths worldwide each year. Laparoscopic resection has become the standard of colorectal cancer surgery, and its main advantages are to shorten the length of hospital stay, reduce postoperative pain, and accelerate patient recovery. However, it has been reported that about 49% of patients undergoing laparoscopic colorectal cancer surgery still have moderate to severe postoperative pain. The insertion of abdominal drainage tube will increase the degree of postoperative pain, especially when patients take deep breaths, exercise or cough, which will increase the demand for postoperative opioids and reduce the quality of postoperative recovery. How to further reduce the postoperative pain of patients, reduce the dosage of opioids, shorten the length of hospital stay, promote the rapid recovery of patients and improve patient satisfaction are our concerns. Intrathecal morphine can provide a good analgesic effect on visceral pain. At present, intrathecal morphine has become a new method of postoperative analgesia, which is used in thoracic, abdominal and obstetrics and gynecology operations. The objective of this study was to investigate the effect of intrathecal morphine on the quality of recovery after laparoscopic colon cancer surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 8, 2024
CompletedFirst Posted
Study publicly available on registry
October 15, 2024
CompletedStudy Start
First participant enrolled
October 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2025
CompletedSeptember 25, 2025
December 1, 2024
1 year
October 8, 2024
September 20, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
QoR15 score at 24 hours after surgery
Day 1 after surgery
Secondary Outcomes (9)
QoR15 scores 48 and 72 hours after surgery
Day 2and 3 after surgery
Morphine consumption equivalent 24, 48, 72 hours after surgery
Day 1,2and 3 after surgery
Rest and cough NRS scores in PACU after surgery
30 minutes after surgery
NRS scores at rest, deep breathing, activity, and cough 24, 48, and 72 hours after surgery
Day 1,2and 3 after surgery
Intraoperative opioid dosage
in surgery
- +4 more secondary outcomes
Study Arms (2)
Intrathecal morphine group
EXPERIMENTALBefore induction of anesthesia, the experimental group received intrathecal morphine in the lumbar segment (L3/4).For our preliminary clinical application, the intrathecal morphine was 3ug/kg
Normal saline group
ACTIVE COMPARATORBefore anesthesia induction, the control group received intrathecal injection of normal saline.
Interventions
The patient was asked to lie on the side, the needle insertion point was located under the guidance of color ultrasound, and after local anesthesia, the needle was inserted into the subarachnoid space at the puncture point and morphine was injected.
After the patient was asked to lie on his side, the injection point was determined under the guidance of color ultrasound. After local anesthesia, the needle was injected into the subarachnoid space and then normal saline was injected.
The patient was in a supine position. The rectus muscle was confirmed to be warping under the guidance of color photography, and the needle was injected with bupivacaine liposomes
Eligibility Criteria
You may qualify if:
- Laparoscopic colorectal cancer surgery under tracheal intubation and general anesthesia is intended
- Agreed to use intravaginal morphine injection and bupivacaine liposomal plane block of transversal muscle after surgery
- ASA Grade I - III
- Over 18 years of age
You may not qualify if:
- Preoperative accident or subjective refusal of surgery
- Nervous system dysfunction
- Contraindications to intraspinal anesthesia
- Preoperative opioid use history
- Patients with abnormal preoperative pain and pain score (NRS) \>3
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sun Yat-Sen University Cancer Center
Guangzhou, Guangdong, China
Related Publications (1)
Zheng L, Lu Y, Lu X, You L, Yu C, Lai J, Xu M, Xie M, Xiao Y, Lai R. Intrathecal Morphine for Enhanced Recovery After Laparoscopic Colorectal Surgery: A Randomized Clinical Trial. JAMA Surg. 2025 Dec 23:e255699. doi: 10.1001/jamasurg.2025.5699. Online ahead of print.
PMID: 41433024DERIVED
MeSH Terms
Interventions
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
October 8, 2024
First Posted
October 15, 2024
Study Start
October 15, 2024
Primary Completion
October 30, 2025
Study Completion
October 30, 2025
Last Updated
September 25, 2025
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share